Next Article in Journal
Prevalence Rate and Associated Risk Factors of Anaemia among under Five Years Children in Ethiopia
Next Article in Special Issue
The Associations of Selenoprotein Genetic Variants with the Risks of Colorectal Adenoma and Colorectal Cancer: Case–Control Studies in Irish and Czech Populations
Previous Article in Journal
Comparative Analysis of Antioxidant Properties of Honey from Poland, Italy, and Spain Based on the Declarations of Producers and Their Results of Melissopalinological Analysis
Previous Article in Special Issue
Critical Role of Maternal Selenium Nutrition in Neurodevelopment: Effects on Offspring Behavior and Neuroinflammatory Profile
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 13
10.3390/nu14132695
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association between Selenium Status and Chronic Kidney Disease in Middle-Aged and Older Chinese Based on CHNS Data

by
Changxiao Xie
1,2,3,†,
Mao Zeng
4,†,
Zumin Shi
5,
Shengping Li
1,2,3,
Ke Jiang
1,2,3 and
Yong Zhao
1,2,3,6,*
1
School of Public Health, Chongqing Medical University, Chongqing 400016, China
2
Research Center for Medicine and Social Development, Chongqing Medical University, Chongqing 400016, China
3
Research Center for Public Health Security, Chongqing Medical University, Chongqing 400016, China
4
Center for Disease Control and Prevention in Shuangliu District of Chengdu, Chengdu 610000, China
5
Human Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar
6
Chongqing Key Laboratory of Child Nutrition and Health, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2022, 14(13), 2695; https://doi.org/10.3390/nu14132695
Submission received: 20 April 2022 / Revised: 24 June 2022 / Accepted: 24 June 2022 / Published: 28 June 2022
(This article belongs to the Special Issue Dietary Selenium Intake and Human Health)
Browse Figures
Versions Notes

Abstract

:
Background: The association between selenium and chronic kidney disease (CKD) remains controversial. Population studies with large samples facilitate the reliability of conclusions. Objective: In this study, we aimed to describe the prevalence of a CKD association with selenium intake in middle-aged and older Chinese. Methods: Data for this study were obtained from the China Health and Nutrition Survey (CHNS). A total of 5381 participants (aged ≥ 45) with biochemical test data were included in the study. Logistic regression models were used to examine the association between diet selenium intake (quartile) and the prevalence of CKD. Results: A total of 942 (17.01%) participants had CKD. The prevalence of CKD was 23.33%, 20.32%, 14.98%, and 9.25% among participants with average selenium intakes of 21.5 ± 4.82, 33.1 ± 2.79, 43.8 ± 3.70, and 67.0 ± 13.97 µg/day, respectively. In the fully adjusted model (Model 3), across the quartiles of selenium intake, the ORs for the prevalence of CKD were 1.00, 1.09 (95% CI 0.69–1.73), 0.82 (95% CI 0.49–1.38), and 0.43 (95% CI 0.22–0.85). The protein intake had a certain diagnostic significance for the selenium intake. Conclusions: An adequate selenium intake may have a positive effect on CKD. The influence of individual weight and location on the effect of selenium on CKD needs to be further explored.

Graphical Abstract

1. Introduction

Chronic kidney disease (CKD) is a chronic kidney structure and function disorder caused by a variety of reasons, of which oxidative stress plays the most important role in its pathogenesis [1]. Globally, in 2017, the prevalence of CKD was 9.1% [2] and 697.5 million cases of CKD were reported. Almost a third of patients with CKD lived in two countries: China (132.3 million cases) and India (115.1 million cases) [2,3]. CKD and its effect on cardiovascular disease resulted in 2.6 million deaths and 35.8 million disability-adjusted life years (DALYs) [2]. It has become a global public health problem with a high disease burden. Diabetes, hypertension, obesity, hyperlipidemia, advanced age, and smoking have been identified as traditional risk factors for CKD [4]. Trace elements such as zinc, manganese, iron, and selenium have also been reported to be involved in the progression of CKD [5,6,7].
In human beings, the nutritional functions of selenium are achieved by 25 selenoproteins that have selenocysteine at their active center [8,9]. Among them, selenium is best known in the form of antioxidant enzymes such as GPx3, the strongest antioxidant enzyme in the body [8,9,10]. The middle-aged and elderly are the populations with a high incidence of various chronic diseases [11]. Studies have shown that a lack of selenium intake was associated with cognitive impairment [12], hypertension [13], and Alzheimer’s disease [14,15]. In addition, considering the physiological characteristics of middle-aged and elderly people with a reduced appetite [16] and digestive capacity [17], they are at a higher risk of an insufficient selenium intake. Middle-aged and elderly people are also susceptible to CKD. The United States Renal Data System report released in 2021 showed that 96.30% of registered ESRD patients in the United States were middle-aged and elderly patients (≥45 years of age) [18].
The kidney, where selenium is most distributed [19], absorbs selenium in plasma through renal tubular epithelial cells to synthesize GPx3 and maintain selenium homeostasis [20,21]. Several studies have shown that selenium levels are associated with the severity of kidney disease [22]. A selenium deficiency causes renal injury through increased oxidative stress and an impaired mitochondrial function [23].
Most of the existing studies on the association between selenium status and CKD focus on the clinical treatment or the molecular level [6,23,24,25] and have controversial results [5,6,24,25]. Selenium is found in different forms in various foods, greatly affecting absorption [26]. Considering that the dietary intake is the main source of selenium for human beings, population research on the association between selenium intake under natural conditions and CKD is lacking. Using data from the China Health and Nutrition Survey (CHNS), we aimed to assess the association between selenium intake and the prevalence of CKD in a Chinese adult population.

2. Methods

2.1. Study Population

The population was derived from the CHNS, a cohort study established between a large number of scholars from the Chinese Center for Disease Control and Prevention and the University of North Carolina at Chapel Hill [27]. Ten wave surveys were conducted from 1989 to 2015 (1989, 1991, 1993, 1997, 2000, 2004, 2006, 2009, 2011, and 2015). A multistage random cluster process was used to draw the sample surveyed in nine provinces. We used a wide-ranging set of socioeconomic factors (e.g., income, employment, and education), demographic measures (e.g., gender and age), and biomarker data (e.g., creatinine, blood pressure, blood glucose, and total cholesterol) collected in 2009. We selected 2009 with creatinine (µmol/L) data (n = 9496) and excluded 3964 participants (<45 years old), 3 pregnant women, and 148 with missing data of selenium intake. Finally, 5381 participants were included (Figure 1).

2.2. Outcome Variable: CKD

CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min per 1.73 m2. We used the Chronic Kidney Disease–Epidemiology Collaboration (CKD-EPI) formula [28] to estimate the eGFR. The creatinine level was determined using a colorimetric assay and a Roche Modular P800 instrument [3].

2.3. Exposure Variables: Selenium Intake

During the 3 day diet survey, trained investigators weighed and recorded the food and condiments from household stocks, markets, gardens, and leftover food waste. The data were collected using a 3 day/24 h dietary survey. Trained investigators weighed and recorded in detail how much food (including condiments) was stored, how much food was purchased (including home-grown), and how much food was left over at the start, middle, and end of the survey. From this, we obtained the food consumption of family members and calculated the intake information of selenium as well as the total food capacity, carbohydrate, fat, and protein intake according to the Chinese Food Composition Table [29]. On the basis of the description of the same cohort, about 93% of the participants were in a stable state of selenium intake [13], so we only used the dietary intake data from 2009. The selenium intake was recoded into quartiles in the analysis.

2.4. Covariates

A structured questionnaire was used to obtain the age (<60 years and ≥60 years); gender (male and female); income as per capita household income (recoded to tertiles as low, medium, and high); urbanization index (recoded to tertiles as low, medium, and high); education (low: illiterate/primary school, medium: junior middle school, high: high middle school or higher and unknown); smoking status (non-smokers, ex-smokers, and current smokers); and alcohol drinking status (yes and no). Physical activity levels were estimated using self-reported activities (including occupation, family, transportation, and recreation) and time spent (metabolic equivalent of task (MET), hours/week) [30].
Physical measurements and a biological sample collection questionnaire were used to obtain the height, weight, systolic blood pressure, diastolic blood pressure, blood glucose level, triglycerides (TGs), cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), creatinine, and other data. All anthropometric measurements were obtained according to China’s Regulations on Hygienic Standards for Anthropometric Methods (WS/T 424-2013) [31]. We defined the BMI status according to the China cut-off (low: BMI < 18.5, normal: 18.5 ≤ BMI < 24, overweight: 24 ≤ BMI < 28, and obesity: BMI ≥ 28 [32]). Hypertension was defined as a mean of three measurements with systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg without taking hypertension medications. Participants who had been diagnosed with hypertension or who were taking anti-hypertensive drugs were also counted [13]. Participants were labeled as having diabetes when their fasting venous plasma glucose ≥ 7.0 mmol/L or if they had been diagnosed with diabetes [33]. The National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) was used to define hyperlipidemia [34]. In addition, all dietary intake information calculated from the Chinese food composition list was included as covariates.

2.5. Statistical Analyses

Stata16.0 (Stata Corporation, College Station, TX, USA) was used for all statistical analyses. We defined the data beyond 1–99% of the data of the energy intake and nutrient intake as outliers and treated them as missing. In the descriptive analysis, the continuous variables were described by the mean (standard deviation) and the categorical variables were described by the number (percentage). Binary logistic regression models were used to analyze the association between selenium and CKD. Three models were adopted: Model 1, without any adjustments; Model 2, adjusted for age, gender, and energy intake; and Model 3, adjusted similar to Model 2 plus protein intake, fat intake, carbohydrate intake, physical activity (MET, hours/week), smoking status (non-smoker, ex-smoker, and current smoker), alcohol drinking (yes or no), income (tertile), urbanization index (tertile), education (low, medium, and high), and BMI (<18.5, 18.5–23.9, 24.0–27.9, or ≥28 kg/m2). The sample size in the fully adjusted model was 2194. The multiplicative interaction between the selenium intake and the potential influencing factors (age, sex, region, alcohol drinking, smoking, hypertension, diabetes, hyperlipidemia, BMI, and physical activity) was analyzed by adding the product of the variables in the regression model. We also performed a subgroup analysis of these factors. A p < 0.05 was considered to be statistically significant for all statistical analyses.

3. Results

Table 1 describes the sample characteristics of selenium intake by quartiles. A total of 5381 participants were included in the study and 942 (17.01%) participants had CKD. A univariate analysis showed that the energy intake, carbohydrate intake, fat intake, and protein intake were positively correlated with the selenium intake whereas age was inversely correlated with the selenium intake. Significant differences in the selenium intake by sex, alcohol consumption, smoking, income, urbanization, region, BMI, and education level were found. The prevalence of diabetes and hyperlipidemia was not statistically associated with the selenium intake, but both hypertension and CKD were found to be at low rates in the high selenium group.
Across the selenium intake quartiles, the prevalence of CKD was 23.33%, 20.32%, 14.98%, and 9.25% (Table 2), respectively. In a logistic regression analysis of CKD and dietary selenium, all three models showed a negative association between the selenium intake and the prevalence of CKD in the highest selenium intake group. In the fully adjusted model, Model 3, the ORs for prevalent CKD were 1.00, 1.09 (95% CI 0.69–1.73), 0.82 (95% CI 0.49–1.38), and 0.43 (95% CI 0.22–0.85) across the quartiles of selenium intake, respectively. The trend was statistically significant. We attempted to include dietary selenium density (µg/1000 kcal) into the logistic regression analysis; the results showed an even stronger association between selenium and CKD (Supplementary Table S1).
No interactions were observed between the selenium intake and age, sex, region, alcohol drinking, hypertension, diabetes, hyperlipidemia, BMI, and physical activity level for the CKD odds (Table 3). Amongst the people aged 60 years or older, the prevalence of CKD was 0.23 (95% CI 0.08–0.67) in the group with the highest selenium intake compared with that in the lowest. Similarly, in the subgroups of females (OR: 0.36, 95% CI 0.14–0.95), non-/ex-smokers (OR: 0.36, 95% CI 0.16–0.81), non-alcohol drinking (OR: 0.32, 95% CI 0.14–0.73), non-hypertensive (OR: 0.38, 95% CI 0.15–0.99), non-diabetic (OR: 0.43, 95% CI 0.22–0.86), non-hyperlipidemia (OR: 0.44, 95% CI 0.19–1.02), and high levels of physical activity (OR: 0.12, 95% CI 0.02–0.61), the highest selenium group was independently associated with a low odds of CKD. A significant negative relationship between the selenium intake and CKD was found in the overweight (OR: 0.09, 95% CI 0.02–0.46), but not obese, individuals. Notably, a significant north–south difference was observed in the relationship between selenium intake and CKD. The selenium intake in the second quartile group was potentially a statistically significant odds factor for CKD in the north (OR: 3.80, 95% CI 1.03–13.98).

4. Discussion

The study subjects included 5381 middle-aged and elderly people from the CHNS project in 2009. Currently, the international recommended intake of dietary selenium for adults varies from 26 µg/day to 75 µg/day [35,36]. In our study, the dietary selenium intake was generally lower than the recommended intake (60 µg/day) set by China [37]. The prevalence of CKD in people aged over 45 years (17.01%) was slightly higher than that in US adults (13.4%) for the same period [18]. Given that our study subjects were of a different race and the average age was older, this difference was considered to be acceptable.
In the fully adjusted model, Model 3, a high dietary selenium intake may have been a protective factor for CKD; this result supported previous research [22]. According to research in Taiwan, plasma selenium was positively correlated with the eGFR and the odds of CKD were 3.35 times higher in the low selenium group than in the high selenium group [3]. In a randomized double-blind placebo-controlled prospective trial of 215 older adults, a significantly better renal function was found in the treatment groups provided with supplements of selenium and coenzyme Q10 than in the control group [25]. Selenium Supplementation can protect the kidneys from renal ischemia [38], heavy metals [3], and mycotoxins [39]. No association between selenium and renal function has been reported. A population-based cross-sectional study in China that included 3553 subjects reported no correlation between serum/urinary selenium and renal function [40]. Fang et al. [5] used the evidence strength criteria proposed by the WHO to classify all the articles on the health effects of selenium included in Medline, Google Scholar, and the China National Knowledge Network (CNKI). No health effects of selenium on CKD were found among the eight beneficial and one adverse health effects identified.
Selenium is not an antioxidant per se, but it acts as a cofactor of antioxidant enzymes [9]. The mechanism of selenium affecting CKD may be related to the following aspects. First, selenium increases the activity of GPx3 in the body [9], which may protect the kidney function by preventing mitochondrial damage caused by elevated oxidative stress [23]. Second, selenium has a positive effect on phagocytes, T cells, and immunoglobulin, thereby enhancing human immunity [8]. Third, selenium affects renal hemodynamics by playing an important role in the thyroid function [41]. Dyslipidemia caused by hypothyroidism may adversely affect the recovery of CKD [42]. In addition, the Wnt/β-catenin pathway may play an important role in renal fibrosis caused by a selenium deficiency [43].
The effect of selenium on CKD varies in different populations. The protective effect of high selenium on CKD was more significant in people aged 60 years and older than among their younger counterparts. This result suggests the significance of selenium Supplementation for middle-aged and elderly people susceptible to CKD. More complex antioxidant mechanisms in women may contribute to a greater sensitivity to selenium [44]. These factors may contribute to the gender difference observed in longevity, given that women live longer than men. Unhealthy lifestyles such as alcohol consumption, smoking, and sedentary behavior [18] were not only direct risk factors for CKD, but also interfered with the normal physiological function of selenium in protecting the kidneys. We found that the odds of CKD decreased with an increased selenium intake in overweight individuals. A controlled clinical trial showed that selenium supplementation reinforced the effects of diet on overweight/obese individuals and increased lean muscle mass [45]. This mechanism may also have a positive influence on the protective effect of selenium on CKD. This may not be the case in obese people because they suffer from high levels of oxidative stress [46] often accompanied by multiple metabolic diseases (including obesity itself [47]), which are strongly correlated with the selenium levels in the human body [48,49]. The results found in our study in our disease subgroups supported this view. Interestingly, regional differences were found in the association between selenium intake and CKD. Consistent with another study on selenium and hypertension, this difference may be due to the uneven distribution of selenium in the soil [13].
Grains, meat, and dairy products contribute to most of the dietary selenium intake [50]. Protein-rich foods contain high levels of selenium and they are associated with the high bioavailability of selenium [50].
In addition to the CKD-EPI equation, the Modification Of Diet In Renal Disease (MDRD) study equation [51] is commonly used to estimate the eGFR. The MDRD equation yielded lower estimates of the eGFR than the CKD-EPI equation [52]. The mean difference between the two equations was small when the eGFR levels were low, but large when the renal function was slightly reduced or near normal [52]. Studies have shown that the CKD-EPI equation is more accurate than the MDRD equation [53], especially in classifying individuals at risk of CKD in middle-aged people with a normal or near normal renal function [54]. We used standardized serum creatinine values in the MDRD equation for estimating the eGFR [51] and the results were similar to the CKD-EPI equation (Supplementary Table S2). The two methods yielded consistent results, confirming the possible benefit of selenium on the onset of CKD.

5. Conclusions

In conclusion, an adequate selenium intake may have a positive effect on the prevention and treatment of CKD. This role is better served by adhering to good lifestyle habits (e.g., continued physical activity, not drinking alcohol, and not smoking) and the absence of other metabolic diseases. The negative association between selenium and CKD found only in overweight people deserves a further investigation. It is also prudent to be cautious about regional differences when providing selenium supplements.
In this study, which was based on a large population sample, we have addressed the gap in domestic research on dietary selenium and CKD and innovatively explored a new method for predicting selenium intake. This study had the following shortcomings. First, we only included data from 2009. The cross-sectional study design did not allow us to specify the causality of all the observed associations, so further evidence is needed. Second, the determination of selenium in human studies is complex and the determined selenium levels can vary significantly even for healthy individuals [55]. Selenoprotein may be included as an indicator in the future [56]. Third, our study lacked data on albuminuria, which is an earlier marker of kidney failure.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu14132695/s1, Table S1: Logistic regression analysis of CKD status and dietary selenium density (quartile) in adults; Table S2: Logistic regression analysis of CKD status (measured by MDRD equation) and dietary selenium (quartile) in adults (≥45 years old).

Author Contributions

C.X. and M.Z. contributed to the conception, analysis, and interpretation of the data and drafted the report. Z.S., S.L. and K.J. contributed to the analysis of the data. Y.Z. supervised the project and agreed to be accountable for all aspects of the work. All authors commented on the previous versions of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a project of the Chongqing Nutrition Society (2019001): Research on dietary selenium intake and its relationship with hypertension and diabetes in middle-aged and older adults in Jiangjin Chongqing. Yong Zhao received research support from the Chongqing Nutrition Society. This research used data from the China Health and Nutrition Survey (CHNS). Many thanks to the National Institute for Nutrition and Health, China Center for Disease Control and Prevention, the Carolina Population Center (P2C HD050924, T32 HD007168), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700), and the NIH Fogarty International Center (D43 TW009077, D43 TW007709).

Institutional Review Board Statement

Ethical review and approval were waived for this study due to which publicly available datasets from the official CHNS website (https://www.cpc.unc.edu/projects/china) were used.

Informed Consent Statement

Written informed consent for the CHNS was reviewed by the University of North Carolina (USA) and the National Institute of Nutrition and Food Safety (China). Informed consent was obtained from all individual participants included in the study.

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available in the CHNS repository, https://www.cpc.unc.edu/projects/china (accessed on 24 April 2022).

Acknowledgments

Data in this research were from China Health and Nutrition Survey (CHNS). We also express our gratitude to Chongqing Nutrition Society’s project (2019001): Research on dietary selenium intake and its relationship with hypertension and diabetes in middle-aged and older adults in Jiangjin Chongqing.

Conflicts of Interest

The authors have no relevant financial or non-financial interests to disclose.

References

  1. Huang, J.; Tang, H.; Zliang, C. Research progress of selenoprotein in kidney diseases. Chin. J. Nephrol. 2020, 36, 165–170. [Google Scholar] [CrossRef]
  2. Collaboration, G.C.K.D. Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020, 395, 709–733. [Google Scholar] [CrossRef] [Green Version]
  3. Wu, C.; Wong, C.; Chung, C.; Wu, M.; Huang, Y.; Ao, P.; Lin, Y.; Lin, Y.; Shiue, H.; Su, C.; et al. The association between plasma selenium and chronic kidney disease related to lead, cadmium and arsenic exposure in a Taiwanese population. Hazard. Mater. 2019, 375, 224–232. [Google Scholar] [CrossRef] [PubMed]
  4. Xie, Y.; Bowe, B.; Mokdad, A.H.; Xian, H.; Yan, Y.; Li, T.; Maddukuri, G.; Tsai, C.Y.; Floyd, T.; Al-Aly, Z. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018, 94, 567–581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Fang, H.; Zhang, Q.; Zhang, S.; Zhang, T.; Pan, F.; Cui, Y.; Thomsen, S.T.; Jakobsen, L.S.; Liu, A.; Pires, S.M. Risk-Benefit Assessment of Consumption of Rice for Adult Men in China. Front. Nutr. 2021, 8, 694370. [Google Scholar] [CrossRef]
  6. Shen, Y.; Yin, Z.; Lv, Y.; Luo, J.; Shi, W.; Fang, J.; Shi, X. Plasma element levels and risk of chronic kidney disease in elderly populations (≥ 90 Years old). Chemosphere 2020, 254, 126809. [Google Scholar] [CrossRef]
  7. Joyce, T.; Rasmussen, P.; Melhem, N.; Clothier, J.; Booth, C.; Sinha, M.D. Vitamin and trace element concentrations in infants and children with chronic kidney disease. Pediatric Nephrol. 2020, 35, 1463–1470. [Google Scholar] [CrossRef] [Green Version]
  8. Rayman, M. Selenium and human health. Lancet 2012, 379, 1256–1268. [Google Scholar] [CrossRef]
  9. Zachara, B. Selenium and selenium-dependent antioxidants in chronic kidney disease. Adv. Clin. Chem. 2015, 68, 131–151. [Google Scholar] [CrossRef]
  10. Gladyshev, V.; Arnér, E.; Berry, M.; Brigelius-Flohé, R.; Bruford, E.; Burk, R.; Carlson, B.; Castellano, S.; Chavatte, L.; Conrad, M.; et al. Selenoprotein Gene Nomenclature. Biol. Chem. 2016, 291, 24036–24040. [Google Scholar] [CrossRef] [Green Version]
  11. Zhang, G.; Tang, F.; Liang, J.; Wang, P. Trajectories of middle-aged and elderly people’s chronic diseases Disability Adjusted Life Years (DALYs): Cohort, socio-economic status and gender disparities. Int. J. Equity Health 2021, 20, 179. [Google Scholar] [CrossRef]
  12. Li, S.; Sun, W.; Zhang, D. Association of Zinc, Iron, Copper, and Selenium Intakes with Low Cognitive Performance in Older Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey (NHANES). J. Alzheimers Dis. 2019, 72, 1145–1157. [Google Scholar] [CrossRef] [PubMed]
  13. Xie, C.; Xian, J.; Zeng, M.; Cai, Z.; Li, S.; Zhao, Y.; Shi, Z. Regional Difference in the Association between the Trajectory of Selenium Intake and Hypertension: A 20-Year Cohort Study. Nutrients 2021, 13, 1501. [Google Scholar] [CrossRef] [PubMed]
  14. Adani, G.; Filippini, T.; Michalke, B.; Vinceti, M. Selenium and Other Trace Elements in the Etiology of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Case-Control Studies. Neuroepidemiology 2020, 54, 1–23. [Google Scholar] [CrossRef] [PubMed]
  15. Aaseth, J.; Skalny, A.V.; Roos, P.M.; Alexander, J.; Aschner, M.; Tinkov, A.A. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease. Int. J. Mol. Sci. 2021, 22, 9461. [Google Scholar] [CrossRef]
  16. Kmieć, Z.; Pétervári, E.; Balaskó, M.; Székely, M. Anorexia of aging. Vitam. Horm. 2013, 92, 319–355. [Google Scholar] [CrossRef]
  17. Soenen, S.; Rayner, C.K.; Jones, K.L.; Horowitz, M. The ageing gastrointestinal tract. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 12–18. [Google Scholar] [CrossRef]
  18. USRDS. Chronic Kidney Disease 2021 Annual Report. Available online: https://adr.usrds.org/2021/chronic-kidney-disease/1-ckd-in-the-general-population (accessed on 8 January 2022).
  19. Zachara, B.; Pawluk, H.; Bloch-Boguslawska, E.; Sliwka, K.; Korenkiewicz, J.; Skok, Z.; Ryć, K. Tissue level, distribution, and total body selenium content in healthy and diseased humans in Poland. Arch. Environ. Health Int. J. 2001, 56, 461–466. [Google Scholar] [CrossRef]
  20. Reinhardt, W.; Dolff, S.; Benson, S.; Broecker-Preuß, M.; Behrendt, S.; Hög, A.; Führer, D.; Schomburg, L.; Köhrle, J. Chronic Kidney Disease Distinctly Affects Relationship Between Selenoprotein P Status and Serum Thyroid Hormone Parameters. Thyroid 2015, 25, 1091–1096. [Google Scholar] [CrossRef]
  21. Burk, R.; Hill, K. Regulation of Selenium Metabolism and Transport. Annu. Rev. Nutr. 2015, 35, 109–134. [Google Scholar] [CrossRef]
  22. Zachara, B.A.; Trafikowska, U.; Adamowicz, A.; Nartowicz, E.; Manitius, J. Selenium, glutathione peroxidases, and some other antioxidant parameters in blood of patients with chronic renal failure. J. Trace Elem. Med. Biol. 2001, 15, 161–166. [Google Scholar] [CrossRef]
  23. Lai, H.; Nie, T.; Zhang, Y.; Chen, Y.; Tao, J.; Lin, T.; Ge, T.; Li, F.; Li, H. Selenium Deficiency-Induced Damage and Altered Expression of Mitochondrial Biogenesis Markers in the Kidneys of Mice. Biol. Trace Elem. Res. 2021, 199, 185–196. [Google Scholar] [CrossRef]
  24. Lv, Y.; Wei, Y.; Zhou, J.; Xue, K.; Guo, Y.; Liu, Y.; Ju, A.; Wu, B.; Zhao, F.; Chen, C.; et al. Human biomonitoring of toxic and essential metals in younger elderly, octogenarians, nonagenarians and centenarians: Analysis of the Healthy Ageing and Biomarkers Cohort Study (HABCS) in China. Environ. Int. 2021, 156, 106717. [Google Scholar] [CrossRef] [PubMed]
  25. Alehagen, U.; Aaseth, J.; Alexander, J.; Brismar, K.; Larsson, A. Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial. Nutrients 2020, 12, 3780. [Google Scholar] [CrossRef]
  26. Kieliszek, M.; Błażejak, S. Current Knowledge on the Importance of Selenium in Food for Living Organisms: A Review. Molecules 2016, 21, 609. [Google Scholar] [CrossRef] [Green Version]
  27. Zhang, B.; Zhai, F.Y.; Du, S.F.; Popkin, B.M. The China Health and Nutrition Survey, 1989–2011. Obes. Rev. 2014, 15, 2–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. O’Callaghan, C.A.; Shine, B.; Lasserson, D.S. Chronic kidney disease: A large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open 2011, 1, e000308. [Google Scholar] [CrossRef] [PubMed]
  29. Yang, Y. China Food Composition Table (Standard Edition), 6th ed.; Peking University Medical Press: Beijing, China, 2018; Volume 1. [Google Scholar]
  30. Ng, S.W.; Norton, E.C.; Popkin, B.M. Why have physical activity levels declined among Chinese adults? Findings from the 1991-2006 China Health and Nutrition Surveys. Soc. Sci. Med. 2009, 68, 1305–1314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Ministry of Health of the People’s Republic of China. WS/T 424-2013 Anthropometric measurements method in health surveillance. 2013. Available online: https://hbba.sacinfo.org.cn/attachment/onlineRead/f31d9c9cd268a22196bbfb3aa9920c00 (accessed on 27 June 2022).
  32. Zhou, B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin. J. Epidemiol. 2002, 23, 5–10. [Google Scholar]
  33. Society, C.D. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chin. J. Pract. Intern. Med. 2018, 38, 292–344. [Google Scholar]
  34. Haynes, J.W.; Barger, E.V. National Cholesterol Education Program: Adult Treatment Panel III Guidelines and the 2004 Update. Available online: https://doi.org/10.1007/978-0-387-76606-5_2 (accessed on 24 April 2022).
  35. Kipp, A.P.; Strohm, D.; Brigelius-Flohé, R.; Schomburg, L.; Bechthold, A.; Leschik-Bonnet, E.; Heseker, H. Revised reference values for selenium intake. J. Trace Elem. Med. Biol. 2015, 32, 195–199. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Thomson, C.D. Selenium and iodine intakes and status in New Zealand and Australia. Br. J. Nutr. 2004, 91, 661–672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Chinese Nutrition Society. Chinese DRIs Handbook; People’s Medical Publishing House: Beijing, China, 2013. [Google Scholar]
  38. Hasanvand, A.; Abbaszadeh, A.; Darabi, S.; Nazari, A.; Gholami, M.; Kharazmkia, A. Evaluation of selenium on kidney function following ischemic injury in rats; protective effects and antioxidant activity. J. Ren. Inj. Prev. 2017, 6, 93–98. [Google Scholar] [CrossRef] [Green Version]
  39. Liu, Y.; Dong, R.; Yang, Y.; Xie, H.; Huang, Y.; Chen, X.; Wang, D.; Zhang, Z. Protective Effect of Organic Selenium on Oxidative Damage and Inflammatory Reaction of Rabbit Kidney Induced by T-2 Toxin. Biol. Trace Elem. Res. 2021, 199, 1833–1842. [Google Scholar] [CrossRef] [PubMed]
  40. Yang, F.; Yi, X.; Guo, J.; Xu, S.; Xiao, Y.; Huang, X.; Duan, Y.; Luo, D.; Xiao, S.; Huang, Z.; et al. Association of plasma and urine metals levels with kidney function: A population-based cross-sectional study in China. Chemosphere 2019, 226, 321–328. [Google Scholar] [CrossRef]
  41. Köhrle, J. Selenium and the thyroid. Curr. Opin. Endocrinol. Diabetes Obes. 2015, 22, 392–401. [Google Scholar] [CrossRef] [PubMed]
  42. Tatar, E.; Sezis Demirci, M.; Kircelli, F.; Gungor, O.; Yaprak, M.; Asci, G.; Basci, A.; Ozkahya, M.; Ok, E. The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients. Int. Urol. Nephrol. 2012, 44, 601–606. [Google Scholar] [CrossRef] [PubMed]
  43. Lin, T.; Tao, J.; Chen, Y.; Zhang, Y.; Li, F.; Zhang, Y.; Han, X.; Zhao, Z.; Liu, G.; Li, H. Selenium Deficiency Leads to Changes in Renal Fibrosis Marker Proteins and Wnt/β-Catenin Signaling Pathway Components. Biol. Trace Elem. Res. 2021, 200, 1127–1139. [Google Scholar] [CrossRef] [PubMed]
  44. Viña, J.; Sastre, J.; Pallardó, F.; Borrás, C. Mitochondrial theory of aging: Importance to explain why females live longer than males. Antioxid. Redox Signal. 2003, 5, 549–556. [Google Scholar] [CrossRef] [PubMed]
  45. Cavedon, E.; Manso, J.; Negro, I.; Censi, S.; Serra, R.; Busetto, L.; Vettor, R.; Plebani, M.; Pezzani, R.; Nacamulli, D.; et al. Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot Study. Int. J. Endocrinol. 2020, 2020, 4802739. [Google Scholar] [CrossRef] [PubMed]
  46. Ozgen, I.T.; Tascilar, M.E.; Bilir, P.; Boyraz, M.; Guncikan, M.N.; Akay, C.; Dundaroz, R. Oxidative stress in obese children and its relation with insulin resistance. J. Pediatric Endocrinol. Metab. 2012, 25, 261–266. [Google Scholar] [CrossRef] [PubMed]
  47. Błażewicz, A.; Szymańska, I.; Dolliver, W.; Suchocki, P.; Turło, J.; Makarewicz, A.; Skórzyńska-Dziduszko, K. Are Obese Patients with Autism Spectrum Disorder More Likely to Be Selenium Deficient? Research Findings on Pre- and Post-Pubertal Children. Nutrients 2020, 12, 3581. [Google Scholar] [CrossRef] [PubMed]
  48. Laclaustra, M.; Navas-Acien, A.; Stranges, S.; Ordovas, J.M.; Guallar, E. Serum selenium concentrations and hypertension in the US Population. Circ. Cardiovasc. Qual. Outcomes 2009, 2, 369–376. [Google Scholar] [CrossRef] [Green Version]
  49. Bleys, J.; Navas-Acien, A.; Stranges, S.; Menke, A.; Miller, E.R., 3rd; Guallar, E. Serum selenium and serum lipids in US adults. Am. J. Clin. Nutr. 2008, 88, 416–423. [Google Scholar] [CrossRef] [Green Version]
  50. Kieliszek, M. Selenium⁻Fascinating Microelement, Properties and Sources in Food. Molecules 2019, 24, 1298. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Levey, A.S.; Coresh, J.; Greene, T.; Marsh, J.; Stevens, L.A.; Kusek, J.W.; Van Lente, F. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 2007, 53, 766–772. [Google Scholar] [CrossRef] [Green Version]
  52. Juutilainen, A.; Kastarinen, H.; Antikainen, R.; Peltonen, M.; Salomaa, V.; Tuomilehto, J.; Jousilahti, P.; Sundvall, J.; Laatikainen, T.; Kastarinen, M. Comparison of the MDRD Study and the CKD-EPI Study equations in evaluating trends of estimated kidney function at population level: Findings from the National FINRISK Study. Nephrol. Dial. Transplant. 2012, 27, 3210–3217. [Google Scholar] [CrossRef] [Green Version]
  53. Stevens, L.A.; Schmid, C.H.; Greene, T.; Zhang, Y.L.; Beck, G.J.; Froissart, M.; Hamm, L.L.; Lewis, J.B.; Mauer, M.; Navis, G.J.; et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am. J. Kidney Dis. 2010, 56, 486–495. [Google Scholar] [CrossRef] [Green Version]
  54. Matsushita, K.; Selvin, E.; Bash, L.D.; Astor, B.C.; Coresh, J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Kidney Dis. 2010, 55, 648–659. [Google Scholar] [CrossRef] [Green Version]
  55. Navarro-Alarcon, M.; Cabrera-Vique, C. Selenium in food and the human body: A review. Sci. Total Environ. 2008, 400, 115–141. [Google Scholar] [CrossRef]
  56. Letsiou, S.; Nomikos, T.; Panagiotakos, D.B.; Pergantis, S.A.; Fragopoulou, E.; Pitsavos, C.; Stefanadis, C.; Antonopoulou, S. Gender-specific distribution of selenium to serum selenoproteins: Associations with total selenium levels, age, smoking, body mass index, and physical activity. BioFactors 2014, 40, 524–535. [Google Scholar] [CrossRef] [PubMed]
Nutrients 14 02695 g001 550
Figure 1. Participant flow chart.
Figure 1. Participant flow chart.
Nutrients 14 02695 g001
Table
Table 1. Sample characteristics by quartiles of Se intake: CHNS (n = 5381).
Table 1. Sample characteristics by quartiles of Se intake: CHNS (n = 5381).
FactorQ1Q2Q3Q4p-Value
N1350136813221341
Se intake (µg/day), mean (SD)21.5 (4.8)33.1 (2.8)43.8 (3.7)67.0 (14.0)
Se intake (µg/day), range7.8~28.228.4~37.838~50.851~114.2
Age, mean (SD)61.8 (10.8)60.1 (10.1) 58.3 (9.3)57.0 (9.0)<0.01
Energy intake (kcal/day), mean (SD)1656.2 (463.8) (n = 1337)2009.9 (512.7) (n = 1367)2215.3 (566.9) (n = 1320)2529.4 (634.1) (n = 1327)<0.01
Carbohydrate intake (g/day), mean (SD)238.4 (80.3) (n = 1337)277.3 (87.0) (n = 1367)299.2 (93.8) (n = 1321)340.6 (108.8) (n = 1337)<0.01
Fat intake (g/day), mean (SD)56.7 (27.4) (n = 1341)70.9 (29.7) (n = 1359)77.9 (32.9) (n = 1303)86.6 (34.6) (n = 1313)<0.01
Protein intake (g/day), mean (SD)44.9 (13.1) (n = 1339)58.2 (13.5) (n = 1368)69.3 (16.5) (n = 1321)83.4 (20.1) (n = 1313)<0.01
Physical activity (MET h/week), mean (SD)172.1 (111.2) (n = 514)169.5 (105.1) (n = 553)165.7 (107.3) (n = 589)177.4 (100.2) (n = 661)0.25
Sex <0.01
Male484 (35.9%)616 (45.0%)645 (48.8%)785 (58.5%)
Female866 (64.1%)752 (55.0%)677 (51.2%)556 (41.5%)
Alcohol <0.01
No1046 (77.7%)959 (70.1%)884 (66.9%)790 (58.9%)
Yes301 (22.3%)409 (29.9%)438 (33.1%)551 (41.1%)
Smoker <0.01
Non-smoker997 (74.0%)935 (68.3%)889 (67.3%)814 (60.7%)
Ex-smoker57 (4.2%)51 (3.7%)49 (3.7%)74 (5.5%)
Current smoker293 (21.8%)382 (27.9%)382 (28.9%)453 (33.8%)
Income <0.01
Low554 (42.7%)437 (33.2%)400 (30.8%)347 (26.3%)
Medium439 (33.9%)449 (34.1%)429 (33.1%)434 (33.0%)
High303 (23.4%)430 (32.7%)468 (36.1%)536 (40.7%)
Urbanization <0.01
Low553 (41.0%)475 (34.7%)377 (28.5%)402 (30.0%)
Medium432 (32.0%)477 (34.9%)438 (33.1%)453 (33.8%)
High365 (27.0%)416 (30.4%)507 (38.4%)486 (36.2%)
Region <0.01
North469 (34.7%)523 (38.2%)556 (42.15)741 (55.3%)
South881 (65.3%) 845 (61.8%) 766 (57.9%) 600 (44.7%)
Education <0.01
Low283 (21.1%)299 (21.9%)264 (20.0%)266 (19.9%)
Medium236 (17.6%)351 (25.7%)360 (27.3%)424 (31.6%)
High198 (14.8%)254 (18.6%)299 (22.7%)325 (24.3%)
Unknown625 (46.6%)461 (33.8%)397 (30.1%)325 (24.3%)
BMI <0.01
Lower123 (9.3%)85 (6.3%)61 (4.7%)32 (2.4%)
Normal699 (53.0%)705 (52.6%)644 (49.4%)635 (48.1%)
Overweight380 (28.8%)423 (31.6%)450 (34.5%)485 (36.7%)
Obesity118 (8.9%)127 (9.5%)149 (11.4%)168 (12.7%)
CKD <0.01
No1035 (76.7%)1090 (79.7%)1124 (85.0%)1217 (90.8%)
Yes315 (23.3%) 278 (20.3%) 198 (15.0%) 124 (9.2%)
Hypertension <0.01
No694 (51.4%)662 (48.4%)671 (50.8%)750 (55.9%)
Yes656 (48.6%) 706 (51.6%) 651 (49.2%) 591 (44.1%)
Diabetes 0.13
No1227 (90.9%)1206 (88.2%)1184 (89.6%)1205 (89.9%)
Yes123 (9.1%) 162 (11.8%)138 (10.4%)136 (10.1%)
Hyperlipidemia 0.10
No870 (64.4%)822 (60.1%)807 (61.1%)843 (62.9%)
Yes480 (35.6%)545 (39.9%)514 (38.9%) 498 (37.1%)
The statistical data are shown as means (SD) for continuous variables and counts (percentages) for categorical variables. The p-values were calculated from an ANOVA or a chi-squared test. CKD, chronic kidney disease; BMI, body mass index. Significant associations are shown in bold type (p < 0.05). We defined Heilongjiang, Liaoning, Shandong, and Henan as the northern regions and Jiangsu, Hubei, Hunan, Guizhou, and Guangxi as the southern regions.
Table
Table 2. Logistic regression analysis of CKD status and dietary selenium (quartile) in adults.
Table 2. Logistic regression analysis of CKD status and dietary selenium (quartile) in adults.
Q1Q2Q3Q4p for Trend
Se intake (µg/day), mean (SD)21.5 (4.82)33.1 (2.79)43.8 (3.70)67.0 (13.97)
case1350136813221341
Prevalence 23.33%20.32%14.98%9.25%
Model 110.838 (0.698–1.005)0.579 (0.475–0.705)0.335 (0.268–0.419)<0.001
Model 211.057 (0.852–1.311)0.897 (0.708–1.137)0.575 (0.435–0.759)<0.001
Model 311.092 (0.69–1.729)0.818 (0.485–1.378)0.427 (0.216–0.845)0.017
Model 1, without any adjustments; Model 2, adjusted for age, gender, and energy intake; Model 3, adjusted as for Model 2 plus protein intake, fat intake, carbohydrate intake, physical activity (MET, hours/week), smoking status (non-smoker, ex-smoker, current smoker), alcohol drinking (yes or no), income (tertile), urbanization index (tertile), education (low, medium, high), and BMI (< 18.5, 18.5–23.9, 24.0–27.9, or ≥ 28 kg/m2). Bold: statistically significant.
Table
Table 3. Subgroup analyses of the association between selenium intake (quartile) and prevalent CKD.
Table 3. Subgroup analyses of the association between selenium intake (quartile) and prevalent CKD.
Q1Q2Q3Q4P for Interaction
Age 0.327
 < 601.001.01 (0.53–2.01)0.86 (0.42–1.77)0.58 (0.24–1.43)
 ≥ 601.001.00 (0.53–1.90)0.55 (0.25–1.19)0.23 (0.08–0.67)
Sex 0.582
 Male1.000.92 (0.47–1.81)0.82 (0.38–1.73)0.41 (0.16–1.04)
 Female1.000.99 (0.53–1.82)0.54 (0.26–1.12)0.36 (0.14–0.95)
Region 0.388
 North1.003.80 (1.03–13.98)1.35 (0.30–6.11)2.36 (0.49–11.43)
 South1.000.97 (0.58–1.62)0.94 (0.51–1.73)0.56 (0.24–1.31)
Alcohol Drinking 0.826
 No1.000.90 (0.53–1.53)0.59 (0.32–1.09)0.32 (0.14–0.73)
 Yes1.001.12 (0.46–2.75)0.74 (0.27–2.08)0.53 (0.16–1.76)
Smoker 0.239
 Non-/ex-smoker1.000.89 (0.52–1.55)0.52 (0.27–0.99)0.36 (0.16–0.81)
 Current smoker1.001.22 (0.54–2.79)1.04 (0.41–2.66)0.38 (0.11–1.30)
Hypertension 0.756
 No1.000.87 (0.46–1.64)0.57 (0.28–1.19)0.38 (0.15–0.99)
 Yes1.001.14 (0.58–2.24)0.79 (0.36–1.71)0.42 (0.16–1.14)
Diabetes 0.248
 No1.000.86 (0.53–1.38)0.66 (0.38–1.14)0.43 (0.22–0.86)
 Yes1.005.09 (0.65–41.13)1.11 (0.11–11.21)0.13 (0.004–4.32)
Hyperlipidemia 0.552
 No1.000.94 (0.54–1.66)0.52 (0.27–1.01)0.44 (0.19–1.02)
 Yes1.001.42 (0.63–3.20)1.20 (0.49–2.92)0.34 (0.10–1.20)
BMI 0.720
 Lower1.000.88 (0.16–4.91)1.66 (0.25–10.96)2.67 (0.22–32.32)
 Normal1.001.17 (0.65–2.13)0.83 (0.42–1.63)0.43 (0.17–1.07)
 Overweight1.000.74 (0.30–1.84)0.24 (0.07–0.78)0.09 (0.02–0.46)
 Obesity1.000.32 (0.025–4.16)0.89 (0.12–6.84)0.79 (0.10–6.03)
Physical activity 0.674
 Low1.001.35 (0.68–2.67)0.93 (0.40–2.13)0.54 (0.18–1.63)
 Medium1.001.09 (0.48–2.48)0.70 (0.29–1.70)0.48 (0.16–1.41)
 High1.000.57 (0.21–1.54)0.32 (0.10–1.06)0.12 (0.02–0.61)
Model adjusted for age, gender, energy intake, protein intake, fat intake, carbohydrate intake, physical activity, smoking status, alcohol drinking, income, urbanization index, education, and BMI. Stratification variables were not adjusted in the corresponding models. Bold: statistically significant.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Xie, C.; Zeng, M.; Shi, Z.; Li, S.; Jiang, K.; Zhao, Y. Association between Selenium Status and Chronic Kidney Disease in Middle-Aged and Older Chinese Based on CHNS Data. Nutrients 2022, 14, 2695. https://doi.org/10.3390/nu14132695

AMA Style

Xie C, Zeng M, Shi Z, Li S, Jiang K, Zhao Y. Association between Selenium Status and Chronic Kidney Disease in Middle-Aged and Older Chinese Based on CHNS Data. Nutrients. 2022; 14(13):2695. https://doi.org/10.3390/nu14132695

Chicago/Turabian Style

Xie, Changxiao, Mao Zeng, Zumin Shi, Shengping Li, Ke Jiang, and Yong Zhao. 2022. "Association between Selenium Status and Chronic Kidney Disease in Middle-Aged and Older Chinese Based on CHNS Data" Nutrients 14, no. 13: 2695. https://doi.org/10.3390/nu14132695

APA Style

Xie, C., Zeng, M., Shi, Z., Li, S., Jiang, K., & Zhao, Y. (2022). Association between Selenium Status and Chronic Kidney Disease in Middle-Aged and Older Chinese Based on CHNS Data. Nutrients, 14(13), 2695. https://doi.org/10.3390/nu14132695

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop